Company Filing History:
Years Active: 2024
Title: The Innovations of Steven Stanway
Introduction
Steven Stanway is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of peptide ligands. With a total of 2 patents to his name, Stanway's work focuses on innovative solutions for medical applications.
Latest Patents
Stanway's latest patents include "Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)" and "Bicyclic peptide ligands specific for TREM2." The first patent relates to polypeptides that are covalently bound to molecular scaffolds, allowing for the creation of multimeric binding complexes. These complexes are designed to bind to TfR1, with potential applications in delivering therapeutic agents for various diseases. The second patent similarly involves polypeptides that bind to TREM2, aiming to address disorders mediated by this receptor. Both inventions also encompass pharmaceutical compositions that utilize these peptide ligands and binding complexes.
Career Highlights
Stanway is currently associated with Bicycletx Limited, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, contributing to innovative therapeutic solutions.
Collaborations
Some of Stanway's notable coworkers include Ellen Gowans and Michael Skynner. Their collaborative efforts enhance the research environment and foster innovation within their projects.
Conclusion
Steven Stanway's contributions to the field of biotechnology through his patents and work at Bicycletx Limited highlight his role as an influential inventor. His innovative approaches to peptide ligands have the potential to significantly impact medical treatments.